-
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
Wednesday, September 14, 2022 - 2:26pm | 418Biotech drug discovery firm Mindset Pharma Inc. (OTCQB: MSSTF) develops next-generation psychedelic and non-psychedelic medicines for neuropsychiatric and neurological disorders. To pursue their goal it received scientific advice from the UK Medicines and Healthcare Products Regulatory Agency...